The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

The US FDA has approved depemokimab as an add-on maintenance therapy for individuals aged 12 years or older with severe asthma, according to a press release from manufacturer GlaxoSmithKline.

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

Among adults with evidence of systemic mast cell activation, bone marrow samples allowed for detection of 13 additional patients with the KIT D816V mutation that were not detected in peripheral blood, ...

Asthma symptoms worsened in children in Vermont and upstate New York exposed to smoke from Canadian wildfires, according to a recent study by UVM.

The number of flu patients in hospital in England has risen by 18%, following a 55% increase the week before. Other UK-wide ...

Calling AQI–lung damage 'not proven' reflects missing long-term Indian studies, not absence of harm, a senior pulmonologist warns. Waiting decades for perfect local data is not scientific caution, he ...

A ministerial claim that there is no direct correlation between air pollution and lung disease contradicts decades of global ...

Experts warn air pollution is a man-made health emergency in India, cutting life expectancy, raising disability, triggering ...

Discover why coughs worsen at night and improve your sleep by trying expert tips like elevating your head at night, staying hydrated, and using cough drops.

Following the holiday toy drive, one boy got to ring the bell to celebrate one year of being tumor-free, a moment that became ...